- Joined
- Oct 28, 2008
- Messages
- 2,569
- Reaction score
- 40
So, we have a bit of an oddball case in our CCU right now. A mid-50s woman was transferred into our hospital after developing pulmonary hypertension and a subsequent PE. She's on Flolan running at about 17ng/min and bosentan. The PE is being treated with enoxaparin 40mg q12 (she's a pretty small woman).
We've been drawing anti-XA levels for the last few days, and each one comes back at about 0.1. The nurse says that the patients been tolerating the injections very well, and the MAR doesn't have any doses missed. We've also made sure that the lab hasn't screwed up.
I've been trying to figure out why the levels are still at pretty much baseline values even with therapeutic dosage. I can't find any literature out there, and any drug interactions would increase the bleeding risk. The attending says that she's seen similar things in pregnant women (she thinks it's hormonal changes in the coagulation cascade), but this patient is definitely not pregnant.
Any ideas?
We've been drawing anti-XA levels for the last few days, and each one comes back at about 0.1. The nurse says that the patients been tolerating the injections very well, and the MAR doesn't have any doses missed. We've also made sure that the lab hasn't screwed up.
I've been trying to figure out why the levels are still at pretty much baseline values even with therapeutic dosage. I can't find any literature out there, and any drug interactions would increase the bleeding risk. The attending says that she's seen similar things in pregnant women (she thinks it's hormonal changes in the coagulation cascade), but this patient is definitely not pregnant.
Any ideas?